Orexinergic System in Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Sleep Medicine
• Pharmacology

Background:

• The orexinergic system, comprising orexins and their receptors, is crucial for regulating sleep-wake cycles.
• Sleep disruption is a prevalent symptom across various neurodegenerative diseases.

Purpose of the Study:

• To review the orexinergic system's role in sleep regulation.
• To examine the orexinergic system's dysregulation in Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis.
• To discuss therapeutic strategies targeting the orexinergic system for these conditions.

Main Methods:

• Literature review of the orexinergic system and its involvement in neurodegeneration.
• Analysis of studies detailing orexin pathway alterations in Alzheimer's, Parkinson's, Huntington's, and multiple sclerosis.
• Synthesis of current research on therapeutic interventions targeting the orexinergic system.

Main Results:

• The orexinergic system is significantly disturbed in Alzheimer's, Parkinson's, Huntington's, and multiple sclerosis.
• Dysregulation of orexins and/or orexin receptors contributes to the pathogenesis of these neurodegenerative diseases.
• Targeting the orexinergic system presents a promising therapeutic avenue for managing these conditions.

Conclusions:

• The orexinergic system's dysregulation is a common feature in major neurodegenerative diseases.
• Understanding these disruptions is key to developing novel treatments.
• Modulating the orexinergic system holds potential for improving sleep and mitigating disease progression.